PCR-Based IVD Tests in the News: Advancing Modern Diagnostics

PCR-based in vitro diagnostic (IVD) tests continue to make headlines in 2026, reflecting their growing importance in routine diagnostics and global health preparedness.

Recent Developments

A major recent breakthrough comes from the launch of a fully automated PCR testing portfolio covering all five hepatitis viruses (A–E). This milestone enables laboratories to perform comprehensive hepatitis diagnostics within a single integrated workflow, improving efficiency and clinical accuracy. (lifesciencenord.de)

At the same time, the industry is shifting toward automation and integrated workflows, where PCR testing – from sample preparation to data analysis – can be completed within one platform. These systems offer high sensitivity, reproducibility, and faster turnaround times, making them increasingly suitable for routine clinical use. (Rapid Microbiology)

Industry Trends

Recent news highlights several key trends shaping PCR-based IVD testing:

• Automation and scalability: Fully integrated PCR systems are reducing manual intervention
• Multi-disease testing: Panels now detect multiple pathogens in a single workflow
• Regulatory focus: Compliance with frameworks like IVDR is becoming essential
• Expansion of applications: From infectious diseases to oncology and transplant monitoring

Conclusion

PCR-based IVD tests are rapidly evolving into more automated, comprehensive, and accessible diagnostic tools. As recent news shows, innovation is focused on improving efficiency, expanding test menus, and meeting stricter regulatory requirements – ensuring PCR remains central to the future of diagnostics.

Resources

• Hepatitis PCR portfolio news (2026):
  https://www.lifesciencenord.de/en/news-events/news/detail/altona-diagnostics-completes-ce-ivd-pcr-portfolio-for-hepatitis-viruses.html
• Automated PCR workflow and assay development:
  https://www.rapidmicrobiology.com/news/reliable-pcr-testing-for-all-five-hepatitis-viruses-with-a-single-workflow
• Industry news summary on PCR portfolio expansion:
  https://clpmag.com/disease-states/infectious-diseases/altona-diagnostics-completes-automated-pcr-portfolio-five-hepatitis-viruses/

📘 Book Your Place: Navigating regulatory compliance for PCR-based IVD tests:
https://ipi.academy/product/details/2754/navigating-regulatory-compliance-whilst-developing-and-distributing-polymerase-chain-reaction-pcr-based-ivd-tests

 

Published on Apr 16, 2026 by Ella Thomas